Article citationsMore>>

Palfi, S., Gurruchaga, J.M., Ralph, G.S., et al. (2014) Long-Term Safety and Tolerability of ProSavin, a Lentiviral Vector-Based Gene Therapy for Parkinson’s Disease: A Dose Escalation, Open-Label, Phase 1/2 Trial. The Lancet, 383, 1138-1146.
http://dx.doi.org/10.1016/S0140-6736(13)61939-X

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top